Andreas Du Bois

14PUBLICATIONS
174CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 25, 2024
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.

Dominik Denschlag, Florian Heitz, Jacobus Pfisterer

|Mar 31, 2023
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group.

Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois

|Feb 09, 2023
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.

Helmut Plett, Enzo Ricciardi, Vlad Vacaru

|Jan 30, 2023
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.

Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle

|Sep 14, 2022
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study.

Majdi Imterat, Nicolò Bizzarri, Robert Fruscio

|Aug 24, 2022
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant.

Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer

Pageof 3

Frequent Collaborators

6 joint publications

Florian Heitz

4 joint publications

Jalid Sehouli

3 joint publications

Alexander Burges

3 joint publications

Stacey J Winham